Ophthalmology Market Articles & Analysis
12 news found
SAN DIEGO–(BUSINESS WIRE)–Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight, announces the acceptance and presentation of a poster highlighting its latest clinical results at the upcoming Global Specialty Lens Symposium (GSLS), a leading eye care conference. The poster spotlights the results ...
“We look forward to the impact this technology will offer patients suffering from cataracts and presbyopia, two of the largest segments of the ophthalmology market.” Nearly 67 million people worldwide are visually impaired due to cataracts, which can lead to blindness if untreated.1 Atia Vision’s modular intraocular lens technology aims to ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has enrolled the first patient into a Phase 2 clinical trial of GLK-301 for the treatment of signs and symptoms of Dry Eye Disease (DED). ...
TearLab Corporation, a global ophthalmic diagnostics company marketing point-of-care laboratory testing, today announced that Adam Szaronos has been appointed President and Chief Executive Officer by the company's Board of Directors, effective immediately. Mr. Szaronos has been instrumental in leading teams and bringing innovations to market to address unmet needs throughout eye care. Mr. ...
BySOFIE
“This partnership in the aesthetics industry is making the vision we had in 2014 a reality, at the time of the spinout of KiOmed from KitoZyme, i.e. creating a platform that would offer an attractive alternative to the usage of hyaluronic acid in three main markets: rheumatology, ophthalmology and aesthetics,” added Mr. Blondel .The dermal fillers ...
Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight, announces its new corporate branding and new website. The new corporate logo was designed to better reflect and illustrate the purpose and passion underlying the Company’s goal to use the MediPrint process to help protect sight by printing ...
Manassas, VA (June 1, 2021) - Notal Vision, Inc., a privately held ophthalmic home monitoring services provider focused on early disease detection and treatment monitoring is pleased to announce the closing of a Series D financing co-led by Soleus Capital and the company's majority shareholder Ganot Capital. Existing shareholders Elron and Evergreen contributed significantly to the round. The ...
Participants discussed patient adoption, market access, pricing and practitioner willingness to prescribe related to MediPrint’s proprietary assets and compared them to current therapies. ...
Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight, announces the successful completion of the first study in its SIGHT (Sustained Innovative Glaucoma and ocular Hypertension Treatment) clinical program aimed at treating mild to moderate glaucoma and ocular hypertension. SIGHT-1 evaluated the ...
“The novel modular design has received positive feedback from industry and key opinion leaders, confirming its value to patients suffering from cataracts and presbyopia, the largest segments of the ophthalmology market.” About Atia Vision, Inc. Atia Vision is a privately held medical device company formed by Shifamed LLC, a Silicon Valley based ...
Optos plc, the leading medical retinal imaging company, part of Nikon Corporation, is pleased to announce the launch of Silverstone at the American Academy of Ophthalmology, San Francisco, CA. Silverstone is the first of its kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT. ...
CAMPBELL, CA – September 11, 2019 – Atia Vision, Inc., a Shifamed portfolio company committed to improving patient outcomes through the development of a novel modular presbyopia- correcting intraocular lens (IOL), today announced its technology will be featured in presentations at two ophthalmology conferences this week in Paris, France. The first presentation will ...